by nobilistx | Jun 23, 2020 | Uncategorized |
Nobilis Therapeutics, a biopharmaceutical company focused on the advancement of innovative CNS therapies, today announced that it has filed an Investigational New Drug application (IND) with the U.S. Food & Drug Administration (FDA) to initiate a Phase 2b clinical...
by nobilistx | Jun 22, 2020 | Uncategorized |
The National Institute on Drug Abuse (NIDA), one of the components of the National Institutes of Health (NIH), announced its 5th “$100,000 for Start a SUD Startup” Challenge. The Challenge goal is to support research ideas that would further an understanding of...